Benzinga | May 13, 2021 07:03AM EDT

CASI Pharmaceuticals Q1 EPS $(0.11) Misses $(0.06) Estimate, Sales $5.74M Beat $5.05M Estimate

CASI Pharmaceuticals (NASDAQ:CASI) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.06) by 83.33 percent. This is a 22.22 percent decrease over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $5.74 million which beat the analyst consensus estimate of $5.05 million by 13.58 percent. This is a 68.41 percent increase over sales of $3.41 million the same period last year.